MUROMACHI CHEMICALS INC.
4885 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大牟田市新勝立町一丁目３８番５
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Muromachi Chemicals Inc. is a Japanese company dedicated to promoting community health through the production and sale of pharmaceutical and medical products. With a strong focus on customization, the company excels in liquid treatment systems tailored to meet specific customer needs, ensuring optimal performance. Their consumer healthcare division is committed to manufacturing health foods designed to bring joy and well-being to customers. Additionally, Muromachi Chemicals offers a diverse range of functional materials, supporting customer development across various markets with both standard and bespoke products. The company's mission emphasizes societal contribution and the pursuit of innovative solutions, enriching lives through meaningful connections and new challenges.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-01-14 08:01 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-01-14 08:00 |
Interim Report
半期報告書－第79期(2024/06/01－2025/05/31)
|
Japanese | 214.1 KB | |
| 2024-09-04 03:00 |
Inside Information Statement
臨時報告書
|
Japanese | 27.6 KB | |
| 2024-08-28 08:34 |
Internal Control over Financial Reporting
内部統制報告書－第78期(2023/06/01－2024/05/31)
|
Japanese | 22.8 KB | |
| 2024-08-28 08:32 |
Annual Report
有価証券報告書－第78期(2023/06/01－2024/05/31)
|
Japanese | 986.7 KB | |
| 2024-08-28 08:32 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-04-12 09:01 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-04-12 09:01 |
Quarterly Report
四半期報告書－第78期第3四半期(2023/12/01－2024/02/29)
|
Japanese | 178.7 KB | |
| 2024-01-12 08:02 |
Quarterly Report
四半期報告書－第78期第2四半期(2023/09/01－2023/11/30)
|
Japanese | 213.9 KB | |
| 2024-01-12 08:02 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2023-10-13 09:02 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2023-10-13 09:01 |
Quarterly Report
四半期報告書－第78期第1四半期(2023/06/01－2023/08/31)
|
Japanese | 182.3 KB | |
| 2023-08-29 03:35 |
Inside Information Statement
臨時報告書
|
Japanese | 24.0 KB | |
| 2023-08-25 08:40 |
Internal Control over Financial Reporting
内部統制報告書－第77期(2022/06/01－2023/05/31)
|
Japanese | 22.2 KB | |
| 2023-08-25 08:39 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |